Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women
- PMID: 17635891
- DOI: 10.1001/jama.298.3.309
Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women
Abstract
Context: The association of triglycerides with incident cardiovascular disease remains controversial. Although triglyceride levels are typically obtained in the fasting state, postprandial hypertriglyceridemia may play an important role in atherosclerosis.
Objective: To determine the association of triglyceride levels (fasting vs nonfasting) and risk of future cardiovascular events.
Design, setting, and participants: Prospective study of 26,509 initially healthy US women (20,118 fasting and 6391 nonfasting) participating in the Women's Health Study, enrolled between November 1992 and July 1995 and undergoing follow-up for a median of 11.4 years. Triglyceride levels were measured in blood samples obtained at time of enrollment.
Main outcome measure: Hazard ratios for incident cardiovascular events (nonfatal myocardial infarction, nonfatal ischemic stroke, coronary revascularization, or cardiovascular death).
Results: At baseline, triglyceride levels in fasting as well as nonfasting women correlated with traditional cardiac risk factors and markers of insulin resistance. During a median follow-up of 11.4 years, 1001 participants experienced an incident cardiovascular event (including 276 nonfatal myocardial infarctions, 265 ischemic strokes, 628 coronary revascularizations, and 163 cardiovascular deaths), for an overall rate of 3.46 cardiovascular events per 1000 person-years of follow-up. After adjusting for age, blood pressure, smoking, and use of hormone therapy, both fasting and nonfasting triglyceride levels predicted cardiovascular events. Among fasting participants, further adjustment for levels of total and high-density lipoprotein cholesterol and measures of insulin resistance weakened this association (fully adjusted hazard ratio [95% confidence interval] for increasing tertiles of triglyceride levels: 1 [reference], 1.21 [0.96-1.52], and 1.09 [0.85-1.41] [P = .90 for trend]). In contrast, nonfasting triglyceride levels maintained a strong independent relationship with cardiovascular events in fully adjusted models (hazard ratio [95% confidence interval] for increasing tertiles of levels: 1 [reference], 1.44 [0.90-2.29], and 1.98 [1.21-3.25] [P = .006 for trend]). In secondary analyses stratified by time since participants' last meal, triglyceride levels measured 2 to 4 hours postprandially had the strongest association with cardiovascular events (fully adjusted hazard ratio [95% confidence interval] for highest vs lowest tertiles of levels, 4.48 [1.98-10.15] [P<.001 for trend]), and this association progressively decreased with longer periods of fasting.
Conclusions: In this cohort of initially healthy women, nonfasting triglyceride levels were associated with incident cardiovascular events, independent of traditional cardiac risk factors, levels of other lipids, and markers of insulin resistance; by contrast, fasting triglyceride levels showed little independent relationship.
Comment in
-
Triglycerides and risk for coronary heart disease.JAMA. 2007 Jul 18;298(3):336-8. doi: 10.1001/jama.298.3.336. JAMA. 2007. PMID: 17635897 No abstract available.
-
Nonfasting triglycerides and cardiovascular risk.JAMA. 2007 Nov 7;298(17):2004-5; author reply 2005-6. doi: 10.1001/jama.298.17.2004-b. JAMA. 2007. PMID: 17986690 No abstract available.
-
Nonfasting triglycerides and cardiovascular risk.JAMA. 2007 Nov 7;298(17):2004; author reply 2005-6. doi: 10.1001/jama.298.17.2004-a. JAMA. 2007. PMID: 17986691 No abstract available.
-
Fasting versus nonfasting triglycerides and the prediction of cardiovascular risk: do we need to revisit the oral triglyceride tolerance test?Clin Chem. 2008 Jan;54(1):11-3. doi: 10.1373/clinchem.2007.097907. Epub 2007 Nov 12. Clin Chem. 2008. PMID: 17998265 No abstract available.
-
Fasting versus nonfasting triglycerides: implications for laboratory measurements.Clin Chem. 2008 Jan;54(1):14-6. doi: 10.1373/clinchem.2007.098863. Epub 2007 Nov 26. Clin Chem. 2008. PMID: 18039717 No abstract available.
Similar articles
-
Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women.JAMA. 2007 Jul 18;298(3):299-308. doi: 10.1001/jama.298.3.299. JAMA. 2007. PMID: 17635890
-
Nonfasting triglycerides and risk of ischemic stroke in the general population.JAMA. 2008 Nov 12;300(18):2142-52. doi: 10.1001/jama.2008.621. JAMA. 2008. PMID: 19001625
-
Relation of triglyceride levels, fasting and nonfasting, to fatal and nonfatal coronary heart disease.Arch Intern Med. 2003 May 12;163(9):1077-83. doi: 10.1001/archinte.163.9.1077. Arch Intern Med. 2003. PMID: 12742806 Clinical Trial.
-
Association of fasting and nonfasting serum triglycerides with cardiovascular disease and the role of remnant-like lipoproteins and small dense LDL.Curr Opin Lipidol. 2008 Aug;19(4):355-61. doi: 10.1097/MOL.0b013e328304b63c. Curr Opin Lipidol. 2008. PMID: 18607182 Review.
-
Nonfasting versus fasting lipid profile for cardiovascular risk prediction.Pathology. 2019 Feb;51(2):131-141. doi: 10.1016/j.pathol.2018.09.062. Epub 2018 Dec 3. Pathology. 2019. PMID: 30522787 Review.
Cited by
-
Beyond the Guidelines: Perspectives on Management of Pediatric Patients with Hypertriglyceridemia.Curr Atheroscler Rep. 2024 Nov;26(11):617-628. doi: 10.1007/s11883-024-01237-z. Epub 2024 Sep 30. Curr Atheroscler Rep. 2024. PMID: 39347913 Free PMC article. Review.
-
Polyphenol-Rich Aronia melanocarpa Fruit Beneficially Impact Cholesterol, Glucose, and Serum and Gut Metabolites: A Randomized Clinical Trial.Foods. 2024 Aug 30;13(17):2768. doi: 10.3390/foods13172768. Foods. 2024. PMID: 39272533 Free PMC article.
-
Manipulation of Post-Prandial Hyperglycaemia in Type 2 Diabetes: An Update for Practitioners.Diabetes Metab Syndr Obes. 2024 Aug 23;17:3111-3130. doi: 10.2147/DMSO.S458894. eCollection 2024. Diabetes Metab Syndr Obes. 2024. PMID: 39206417 Free PMC article. Review.
-
The need for a prognostic biomarker and challenge test for phenotypic flexibility.Nutr Diabetes. 2024 Aug 28;14(1):70. doi: 10.1038/s41387-024-00329-8. Nutr Diabetes. 2024. PMID: 39198423 Free PMC article. No abstract available.
-
Beyond LDL-C: unravelling the residual atherosclerotic cardiovascular disease risk landscape-focus on hypertriglyceridaemia.Front Cardiovasc Med. 2024 Aug 7;11:1389106. doi: 10.3389/fcvm.2024.1389106. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 39171323 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
